Cargando…
Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients
OBJECTIVE: This study aimed to investigate the pathological effects of long-term postoperative endocrine medication on the endometrium in breast cancer patients. METHODS: Data of 99 patients with primary breast cancer who underwent hysteroscopy and obtained endometrial biopsy from 1 June 2018 to 31...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460202/ https://www.ncbi.nlm.nih.gov/pubmed/37637707 http://dx.doi.org/10.2147/IJGM.S417965 |
_version_ | 1785097591498735616 |
---|---|
author | He, Yue Li, Yu-He Geng, Yu-Ning Liu, Aihui Gao, Feng-Yun Ji, Chen Liu, Yang Wang, Ming Li, Xing-Ming Wang, Yan Wu, Yu-Mei |
author_facet | He, Yue Li, Yu-He Geng, Yu-Ning Liu, Aihui Gao, Feng-Yun Ji, Chen Liu, Yang Wang, Ming Li, Xing-Ming Wang, Yan Wu, Yu-Mei |
author_sort | He, Yue |
collection | PubMed |
description | OBJECTIVE: This study aimed to investigate the pathological effects of long-term postoperative endocrine medication on the endometrium in breast cancer patients. METHODS: Data of 99 patients with primary breast cancer who underwent hysteroscopy and obtained endometrial biopsy from 1 June 2018 to 31 December 2021 at the Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital were prospectively collected. RESULTS: Hysteroscopy was performed followed by endometrial histopathological examination in 99 breast cancer patients, including 44 taking tamoxifen (TAM), 26 taking other endocrine drugs, and 29 not taking endocrine drugs. The endometrial thickness in the TAM group was significantly higher than that in the other endocrine drug groups and the group not taking endocrine drugs (p=0.017). The receiver operating characteristic curves for the abnormal premenopausal endometrial thickening were plotted in this study; an endometrial thickness of 15.5 mm seen on ultrasound could be used as the most accurate ultrasound diagnostic threshold for the diagnosis of abnormal premenopausal endometrial hyperplasia, with an area under the curve of 0.888 (95% CI: 0.716, 1.000), a sensitivity of 100%, and a specificity of 75%, which was consistent with the results of our previous retrospective study. An endometrial thickness of ≥5 mm in postmenopausal women with breast cancer taking TAM was still used as the cut-off value for routine ultrasound diagnosis of abnormal postmenopausal endometrial hyperplasia. CONCLUSION: An ultrasound endometrial thickness (proliferative phase) of >15 mm in premenopausal patients can be used as the most accurate ultrasound diagnostic threshold for the diagnosis of abnormal endometrial hyperplasia. After menopause, an ultrasound endometrial thickness of ≥5 mm is still used as the criterion for diagnosing abnormal endometrial hyperplasia. Older patients should be monitored for signs of vaginal bleeding and fluid discharge, and hysteroscopy should be performed if necessary to ascertain the endometrial condition. |
format | Online Article Text |
id | pubmed-10460202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-104602022023-08-27 Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients He, Yue Li, Yu-He Geng, Yu-Ning Liu, Aihui Gao, Feng-Yun Ji, Chen Liu, Yang Wang, Ming Li, Xing-Ming Wang, Yan Wu, Yu-Mei Int J Gen Med Original Research OBJECTIVE: This study aimed to investigate the pathological effects of long-term postoperative endocrine medication on the endometrium in breast cancer patients. METHODS: Data of 99 patients with primary breast cancer who underwent hysteroscopy and obtained endometrial biopsy from 1 June 2018 to 31 December 2021 at the Beijing Obstetrics and Gynecology Hospital, Capital Medical University. Beijing Maternal and Child Health Care Hospital were prospectively collected. RESULTS: Hysteroscopy was performed followed by endometrial histopathological examination in 99 breast cancer patients, including 44 taking tamoxifen (TAM), 26 taking other endocrine drugs, and 29 not taking endocrine drugs. The endometrial thickness in the TAM group was significantly higher than that in the other endocrine drug groups and the group not taking endocrine drugs (p=0.017). The receiver operating characteristic curves for the abnormal premenopausal endometrial thickening were plotted in this study; an endometrial thickness of 15.5 mm seen on ultrasound could be used as the most accurate ultrasound diagnostic threshold for the diagnosis of abnormal premenopausal endometrial hyperplasia, with an area under the curve of 0.888 (95% CI: 0.716, 1.000), a sensitivity of 100%, and a specificity of 75%, which was consistent with the results of our previous retrospective study. An endometrial thickness of ≥5 mm in postmenopausal women with breast cancer taking TAM was still used as the cut-off value for routine ultrasound diagnosis of abnormal postmenopausal endometrial hyperplasia. CONCLUSION: An ultrasound endometrial thickness (proliferative phase) of >15 mm in premenopausal patients can be used as the most accurate ultrasound diagnostic threshold for the diagnosis of abnormal endometrial hyperplasia. After menopause, an ultrasound endometrial thickness of ≥5 mm is still used as the criterion for diagnosing abnormal endometrial hyperplasia. Older patients should be monitored for signs of vaginal bleeding and fluid discharge, and hysteroscopy should be performed if necessary to ascertain the endometrial condition. Dove 2023-08-22 /pmc/articles/PMC10460202/ /pubmed/37637707 http://dx.doi.org/10.2147/IJGM.S417965 Text en © 2023 He et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research He, Yue Li, Yu-He Geng, Yu-Ning Liu, Aihui Gao, Feng-Yun Ji, Chen Liu, Yang Wang, Ming Li, Xing-Ming Wang, Yan Wu, Yu-Mei Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients |
title | Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients |
title_full | Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients |
title_fullStr | Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients |
title_full_unstemmed | Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients |
title_short | Prospective Exploratory Study of the Effects of Postoperative Endocrine Medication on the Endometrium in Breast Cancer Patients |
title_sort | prospective exploratory study of the effects of postoperative endocrine medication on the endometrium in breast cancer patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460202/ https://www.ncbi.nlm.nih.gov/pubmed/37637707 http://dx.doi.org/10.2147/IJGM.S417965 |
work_keys_str_mv | AT heyue prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT liyuhe prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT gengyuning prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT liuaihui prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT gaofengyun prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT jichen prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT liuyang prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT wangming prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT lixingming prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT wangyan prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients AT wuyumei prospectiveexploratorystudyoftheeffectsofpostoperativeendocrinemedicationontheendometriuminbreastcancerpatients |